Korea Investment Corp Dexcom Inc Transaction History

Korea Investment Corp

  • $43.6 Billion
  • Q2 2025

A detailed history of Korea Investment Corp transactions in Dexcom Inc stock. As of the latest transaction made, Korea Investment Corp holds 379,163 shares of DXCM stock, worth $25.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
379,163
Previous 183,983 106.09%
Holding current value
$25.1 Million
Previous $12.6 Million 163.43%
% of portfolio
0.08%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$59.83 - $87.57 $11.7 Million - $17.1 Million
195,180 Added 106.09%
379,163 $33.1 Million
Q1 2025

May 14, 2025
SELL
$67.74 - $90.75 $10.2 Million - $13.7 Million
-150,900 Reduced 45.06%
183,983 $12.6 Million
Q4 2024

Feb 12, 2025
BUY
$65.68 - $81.01 $26,272 - $32,404
400 Added 0.12%
334,883 $26 Million
Q3 2024

Nov 13, 2024
SELL
$64.0 - $116.06 $98,880 - $179,312
-1,545 Reduced 0.46%
334,483 $22.4 Million
Q2 2024

Aug 13, 2024
SELL
$110.31 - $140.45 $10.1 Million - $12.8 Million
-91,450 Reduced 21.39%
336,028 $38.1 Million
Q1 2024

May 14, 2024
BUY
$114.22 - $140.1 $1.76 Million - $2.16 Million
15,450 Added 3.75%
427,478 $59.3 Million
Q4 2023

Feb 13, 2024
SELL
$75.49 - $124.16 $3.48 Million - $5.72 Million
-46,054 Reduced 10.05%
412,028 $51.1 Million
Q3 2023

Nov 13, 2023
SELL
$86.06 - $137.93 $10.3 Million - $16.4 Million
-119,232 Reduced 20.65%
458,082 $42.7 Million
Q2 2023

Aug 11, 2023
BUY
$112.47 - $130.98 $25.6 Million - $29.9 Million
227,938 Added 65.24%
577,314 $74.2 Million
Q1 2023

May 12, 2023
BUY
$104.0 - $122.92 $15.4 Million - $18.2 Million
148,061 Added 73.55%
349,376 $40.6 Million
Q4 2022

Feb 13, 2023
SELL
$84.98 - $122.67 $2.01 Million - $2.89 Million
-23,596 Reduced 10.49%
201,315 $22.8 Million
Q3 2022

Nov 10, 2022
BUY
$76.35 - $94.18 $6.99 Million - $8.62 Million
91,523 Added 68.61%
224,911 $18.1 Million
Q2 2022

Aug 12, 2022
BUY
$67.99 - $132.89 $7.54 Million - $14.7 Million
110,888 Added 492.84%
133,388 $9.94 Million
Q1 2022

May 13, 2022
SELL
$94.08 - $130.2 $178,752 - $247,379
-1,900 Reduced 7.79%
22,500 $11.5 Million
Q4 2021

Feb 09, 2022
BUY
$129.87 - $162.82 $896,103 - $1.12 Million
6,900 Added 39.43%
24,400 $13.1 Million
Q3 2021

Nov 12, 2021
SELL
$106.71 - $143.18 $256,103 - $343,632
-2,400 Reduced 12.06%
17,500 $9.57 Million
Q2 2021

Aug 12, 2021
SELL
$80.99 - $107.93 $8,098 - $10,793
-100 Reduced 0.5%
19,900 $8.5 Million
Q1 2021

May 13, 2021
SELL
$84.79 - $104.74 $644,404 - $796,024
-7,600 Reduced 27.54%
20,000 $7.19 Million
Q4 2020

Feb 10, 2021
SELL
$78.0 - $104.5 $2.79 Million - $3.74 Million
-35,800 Reduced 56.47%
27,600 $10.2 Million
Q3 2020

Nov 12, 2020
BUY
$95.51 - $112.95 $869,141 - $1.03 Million
9,100 Added 16.76%
63,400 $26.1 Million
Q2 2020

Aug 12, 2020
BUY
$62.68 - $105.34 $1.57 Million - $2.64 Million
25,100 Added 85.96%
54,300 $22 Million
Q1 2020

May 14, 2020
BUY
$47.79 - $75.63 $1.31 Million - $2.07 Million
27,400 Added 1522.22%
29,200 $7.86 Million
Q4 2019

Feb 11, 2020
SELL
$36.62 - $57.29 $483,383 - $756,228
-13,200 Reduced 88.0%
1,800 $394,000
Q3 2019

Nov 12, 2019
SELL
$35.53 - $43.8 $650,199 - $801,540
-18,300 Reduced 54.95%
15,000 $2.24 Million
Q2 2019

Aug 12, 2019
BUY
$27.84 - $38.92 $5,568 - $7,784
200 Added 0.6%
33,300 $4.99 Million
Q1 2019

May 15, 2019
BUY
$28.07 - $38.18 $766,311 - $1.04 Million
27,300 Added 470.69%
33,100 $3.94 Million
Q4 2018

Feb 13, 2019
BUY
$26.99 - $37.37 $156,542 - $216,745
5,800 New
5,800 $695,000

Others Institutions Holding DXCM

# of Institutions
1,108
Shares Held
368M
Call Options Held
5.32M
Put Options Held
5.18M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $25.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Korea Investment Corp Portfolio

Follow Korea Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email